Literature DB >> 14624733

Gonorrhoea resurgence in Canada.

Lisa Hansen1, Tom Wong, Maureen Perrin.   

Abstract

After several years of decline, reported gonorrhoea rates in Canada have recently increased substantially. National goals for gonorrhoea control were developed in 1997, but it appears that reliance on secular trends is insufficient to attain the goal of eliminating locally transmitted infection by Neisseria gonorrhoeae by 2010. We have examined disease surveillance reports from 1994 to 2001 inclusive to assess demographic and epidemiologic trends in reported cases of gonococcal infection. Since 1997, reported cases have increased by 53% among men and 33% among women. The largest proportion of cases in women is in those aged 15-24; the most dramatic increase in males has been among those aged 30-39. Reasons for the resurgence remain unclear, but disease reports indicate that renewed attention to enhanced surveillance and targeted prevention are essential for gonorrhoea control in Canada.

Entities:  

Mesh:

Year:  2003        PMID: 14624733     DOI: 10.1258/09564620360719741

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  4 in total

1.  The laboratory diagnosis of Neisseria gonorrhoeae.

Authors:  Lai-King Ng; Irene E Martin
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-01       Impact factor: 2.471

2.  Demographics, sexual risk behaviours and uptake of screening for sexually transmitted infections among attendees of a weekly women-only community clinic program.

Authors:  Melanie L A Rusch; Jean A Shoveller; Susan Burgess; Karen Stancer; David M Patrick; Mark W Tyndall
Journal:  Can J Public Health       Date:  2008 Jul-Aug

3.  Epidemiology of infectious syphilis in Ottawa. Recurring themes revisited.

Authors:  Aviva Leber; Paul MacPherson; B Craig Lee
Journal:  Can J Public Health       Date:  2008 Sep-Oct

4.  Sexually Transmitted Diseases in Travelers.

Authors:  Noreen A Hynes
Journal:  Curr Infect Dis Rep       Date:  2005-03       Impact factor: 3.663

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.